AbbVie's deal for Allergan will give it a new revenue stream in Botox to a potential revenue drop from arthritis drug Humira, which will lose patent protection.
View full coverage on Google NewsAbbVie Rebounds as Market Warms to Allergan Deal, Botox Potential - TheStreet.com
Read More
Bagikan Berita Ini
0 Response to "AbbVie Rebounds as Market Warms to Allergan Deal, Botox Potential - TheStreet.com"
Post a Comment